Scientists hunt for gut bacteria clues to stop cancer Drug's harsh side effect
NCT ID NCT07264985
Summary
This study aims to understand why a common breast cancer drug, pyrotinib, causes severe diarrhea in many patients. Researchers will observe 60 patients, comparing the gut bacteria of those who get diarrhea with those who don't. The goal is to find bacterial patterns that might predict or explain this side effect, which could inform future ways to prevent it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hubei Cancer Hospital
Wuhan, Hubei, 430079, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.